SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905148-18-000714
Filing Date
2018-08-15
Accepted
2018-08-15 21:00:30
Documents
2
Period of Report
2018-08-13

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1400
2 efc18-529_ex241.htm EX-24.1 12025
  Complete submission text file 0000905148-18-000714.txt   14715
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 508 WRANGLER DRIVE, SUITE 100 COPPELL TX 75019
Business Address
Smith Cynthia (Reporting) CIK: 0001609480 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36281 | Film No.: 181022184